Zealand Pharma - Interim Report for H1 2013 (Un-Audited)
Published: Aug 29, 2013
Zealand Pharma A/S (CVR no. 20 04 50 78) (NASDAQ OMX Copenhagen: ZEAL) (“Zealand”), a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs, today announced its un-audited interim report for the six-month period, 1 January to 30 June 2013.
Help employers find you! Check out all the jobs and post your resume.